Menopause in Nepal: Symptoms, Stages and Specialist Care in Pokhara

Menopause is not a disease — it is a natural biological transition marking the end of menstrual cycles and the reproductive years. But the hormonal changes of menopause have real, measurable effects on a woman’s body and quality of life. Hot flashes, sleep disruption, mood changes, vaginal dryness, and accelerated bone loss are not inevitable or untreatable — they are manageable with the right medical support.

In Nepal, menopause is often not discussed openly. Women in their late 40s and 50s experiencing significant symptoms are frequently told to simply accept them as “old age.” The result is years of unnecessary suffering from conditions that respond well to treatment. A&B International Hospital in Pokhara provides specialist menopause assessment and individualized management for women in the Gandaki Province.

What Is the Difference Between Perimenopause, Menopause, and Post-Menopause?

Perimenopause, menopause, and post-menopause are three sequential stages of the same hormonal transition. Understanding which stage a woman is in guides investigation and treatment decisions.

Perimenopause: The transitional period before menopause, typically lasting 4–8 years, during which ovarian estrogen production becomes irregular and declining. Periods become irregular — longer, shorter, heavier, or lighter. Hot flashes, sleep disturbance, and mood changes may begin in perimenopause, even while periods are still occurring. FSH levels are elevated. Women remain potentially fertile in perimenopause.

Menopause: Defined retrospectively as 12 consecutive months without a menstrual period — in the absence of other causes such as pregnancy, breastfeeding, or illness. The average age of menopause is 48–51 years in Nepal and South Asia — slightly earlier than the global average of 51–52 years.

Post-menopause: The period following menopause, lasting for the rest of the woman’s life. Estrogen levels stabilize at a low level. Symptoms that were prominent in perimenopause may continue or lessen. Long-term health risks — osteoporosis and cardiovascular disease — increase progressively throughout post-menopause.

What Is the Average Age of Menopause in Nepal and South Asia?

Menopause occurs earlier in South Asian women, including Nepali women, than in Western European or North American populations. The average age of natural menopause in Nepal is approximately 48–51 years, compared to 51–52 years in Western populations.

Factors associated with earlier menopause in Nepal include:

• Nutritional deficiencies (undernutrition, inadequate micronutrients)
• Higher parity (more pregnancies)
• Smoking history
• Lower socioeconomic status
• Genetic predisposition

Premature ovarian insufficiency (POI) — loss of normal ovarian function before age 40 — affects approximately 1% of women and requires specialist evaluation. It is associated with significant long-term health risks, particularly bone loss, and requires hormonal management.

What Symptoms Does Menopause Cause?

Menopause symptoms vary significantly between women — some experience severe disruption to daily life, others transition with minimal symptoms. The symptoms are caused by declining and fluctuating estrogen levels.

Vasomotor symptoms:

• Hot flashes: Sudden intense warmth spreading from the chest to the neck and face, often with sweating and flushing. Last 1–5 minutes. Frequency ranges from occasional to dozens per day. Hot flashes disturb sleep when they occur at night (night sweats).
• Night sweats: Nighttime hot flashes that drench clothing and sheets — a major cause of sleep disruption and fatigue

Genitourinary symptoms (Genitourinary Syndrome of Menopause — GSM):

• Vaginal dryness: Decreased estrogen thins the vaginal walls and reduces lubrication. Causes discomfort during sexual intercourse (dyspareunia) and increased susceptibility to vaginal infections.
• Urinary frequency and urgency: Estrogen deficiency affects the urethral and bladder tissues — contributing to urgency, recurrent UTIs, and urinary incontinence

Mood and cognitive symptoms:

• Mood changes: Irritability, anxiety, and low mood — partly from hormonal fluctuation, partly from sleep deprivation
• Cognitive changes: Memory lapses, concentration difficulties — often described as “brain fog.” Typically mild and reversible.

Sleep disturbance: Insomnia is common — difficulty falling asleep, staying asleep, or waking early. Night sweats compound this significantly.

Bone loss: The rate of bone loss accelerates sharply in the first 5–10 years after menopause. A woman can lose 1–3% of bone mass per year during early post-menopause, creating significant osteoporosis risk and increased fracture risk.

How Is Menopause Diagnosed?

Menopause is a clinical diagnosis — in a woman over 45 with typical symptoms and no periods for 12 months, no blood test is required to confirm the diagnosis.

Blood tests are used when:

• The woman is under 45 and premature menopause is suspected
• The diagnosis is uncertain (e.g., irregular periods in a woman who might be pregnant or perimenopausal)
• FSH measurement is needed to assess ovarian function

Useful blood tests:

• FSH (follicle-stimulating hormone): Elevated (>40 IU/L on two occasions 4–6 weeks apart) confirms ovarian insufficiency
• Estradiol: Low in menopause
• TSH: To rule out thyroid disease as a cause of symptoms (thyroid conditions cause hot flashes, mood changes, and irregular periods that mimic menopause)
• Bone mineral density (DEXA scan): Not a diagnostic test for menopause itself, but recommended to assess for osteoporosis at menopause; coordinated from A&B

What Is Hormone Replacement Therapy (HRT) and Who Should Take It?

Hormone replacement therapy (HRT) is the most effective treatment for menopausal symptoms. It replaces the estrogen (and where appropriate, progesterone) that the ovaries are no longer producing, relieving hot flashes, night sweats, vaginal dryness, mood changes, and protecting against bone loss.

Types of HRT:

• Combined HRT (estrogen + progesterone): Required for women with a uterus — the progestogen protects the endometrial lining from the stimulatory effect of estrogen alone
• Estrogen-only HRT: Only appropriate for women who have had a hysterectomy

Benefits of HRT:

• Effectively eliminates or greatly reduces hot flashes and night sweats (>80% improvement)
• Relieves vaginal dryness and dyspareunia
• Improves sleep and mood
• Prevents osteoporotic fractures (a real and significant benefit)
• Reduces risk of diabetes and possibly cardiovascular disease when started within 10 years of menopause (the “timing hypothesis”)

Risks of HRT:

• Breast cancer: The Women’s Health Initiative (WHI) study raised concern. In context: combined HRT is associated with a small increase in breast cancer risk after 5 years of use — the increase is similar to the risk from drinking one glass of wine per day or being overweight. Estrogen-only HRT does not increase breast cancer risk. Transdermal HRT (patch or gel) has a lower clot risk than oral HRT.
• Venous thromboembolism: Oral estrogen increases clot risk — transdermal routes do not. Women with clot risk factors should use transdermal HRT.

The decision to start HRT is individualized. For most women under 60 with significant symptoms and no contraindications, the benefits of HRT substantially outweigh the risks.

What Are the Non-Hormonal Treatment Options for Menopause?

For women who cannot or choose not to use HRT, non-hormonal options address specific symptoms with varying levels of evidence.

For hot flashes and night sweats:

• SSRIs/SNRIs (paroxetine, venlafaxine, escitalopram): Reduce hot flash frequency by 50–60%. The best-evidenced non-hormonal option.
• Gabapentin: Effective for hot flashes and sleep disruption — particularly useful for night sweats
• Clonidine: Modest evidence; less commonly used
• Cognitive behavioral therapy (CBT): Structured psychological approach to managing hot flash perception and sleep disruption — effective in women who engage with it
• Phytoestrogens (soy, red clover): Weak plant estrogens; modest evidence; acceptable as dietary addition, not a replacement for HRT

For vaginal dryness (GSM):

• Topical vaginal estrogen (pessary, cream, ring): Very small doses applied locally restore vaginal health without significant systemic absorption — appropriate for women who cannot take systemic HRT
• Non-hormonal vaginal lubricants and moisturizers: OTC products that provide symptom relief for mild dryness without hormonal effect

How Does Menopause Affect Bone Health and What Should Women Do?

Bone health in menopause deserves specific attention in Nepal, where calcium intake and vitamin D status are often suboptimal, increasing the risk of osteoporosis and fracture.

Recommendations at A&B for bone health at menopause:

• Calcium intake 1000–1200 mg/day through diet and supplementation
• Vitamin D supplementation 1000–2000 IU/day (many Nepali women are deficient despite sun exposure)
• Weight-bearing exercise (walking, light resistance training) stimulates bone formation
• Avoid smoking and limit alcohol
• DEXA scan (bone density measurement) — recommended at menopause to establish baseline; repeated at 2–3 year intervals for women on treatment
• Bisphosphonate therapy (alendronate, risedronate) where osteoporosis is confirmed

Specialist Menopause Care in Pokhara at A&B International Hospital

Menopause symptoms are not something to simply endure. With the right support, this transition can be managed effectively. A&B International Hospital provides specialist gynecologic consultation for perimenopause and menopause in Pokhara.

A&B International Hospital

Pokhara-02, Bindhyaabasini

Phone: +977 061-412512

Website: abinthospital.com

ECHS-eligible patients receive cashless gynecology care. Appointments available by call or walk-in. Confidential consultations for all women’s health concerns.